Botulism

Definition | Aetiology | Pathophysiology | Risk Factors | Signs and Symptoms | Investigations | Management

Definition

Botulism is a rare but life threatening neuroparalytic disorder caused by the neurotoxins of Clostridium botulinum, leading to flaccid paralysis and autonomic dysfunction.

Aetiology

  • Caused by Clostridium botulinum, a spore-forming, Gram-positive anaerobic bacterium.
  • Botulinum toxin blocks acetylcholine release at neuromuscular junctions, leading to paralysis.
  • Three main types:
    • Foodborne botulism: ingestion of preformed toxin in contaminated food (home-canned or fermented foods).
    • Infant botulism: ingestion of spores, which germinate and produce toxin in the immature gut.
    • Wound botulism: bacterial growth in contaminated wounds, often linked to IV drug use.

Pathophysiology

  • Botulinum toxin irreversibly inhibits acetylcholine release at presynaptic terminals.
  • Leads to descending flaccid paralysis with autonomic dysfunction.
  • Recovery requires regeneration of nerve terminals, which may take weeks to months.

Risk Factors

  • Consumption of improperly preserved or home-canned foods.
  • Infants under 12 months ingesting honey (risk of infant botulism).
  • Injection drug use (wound botulism).
  • Soil exposure in traumatic wounds.

Signs and Symptoms

  • Foodborne botulism:
    • Acute onset of bilateral, descending weakness.
    • Cranial nerve palsies (diplopia, ptosis, dysphagia, dysarthria).
    • Symmetric flaccid paralysis progressing to respiratory failure.
    • Autonomic dysfunction (dry mouth, constipation, urinary retention).
  • Infant botulism:
    • Floppy baby syndrome (generalised hypotonia, weak cry, poor feeding).
    • Constipation (often the first symptom).
  • Wound botulism: similar to foodborne but without gastrointestinal symptoms.

Investigations

  • Clinical diagnosis: based on characteristic neurological symptoms and history.
  • Stool or serum toxin assay: detects botulinum toxin.
  • Electromyography (EMG): shows characteristic findings (decreased compound muscle action potential with incremental response to repetitive nerve stimulation).
  • Wound culture: for suspected wound botulism.

Management

1. Supportive Care:

  • Admission to intensive care for respiratory monitoring.
  • Mechanical ventilation if respiratory failure occurs.
  • Nasogastric feeding if swallowing is impaired.

2. Antitoxin Therapy:

  • Botulinum antitoxin (equine derived) for adults.
  • Human derived botulism immune globulin (BIG-IV) for infant botulism.

3. Antibiotics:

  • Not indicated for foodborne or infant botulism.
  • For wound botulism: penicillin or metronidazole after antitoxin administration.

4. Prevention:

  • Proper food preservation and storage.
  • Avoid giving honey to infants under 12 months.
  • Wound care and harm reduction strategies for IV drug users.

5. Referral:

  • Infectious diseases: for diagnosis and toxin management.
  • Intensive care: for respiratory support.
  • Neurology: for electrophysiological studies if diagnosis is unclear.